These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6165258)

  • 21. Pharmacokinetics of propranolol, quinidine, procainamide and lidocaine in chronic renal disease.
    Lowenthal DT
    Am J Med; 1977 Apr; 62(4):532-8. PubMed ID: 851126
    [No Abstract]   [Full Text] [Related]  

  • 22. Displacement of lidocaine from human plasma proteins by disopyramide.
    Bonde J; Jensen NM; Burgaard P; Angelo HR; Graudal N; Kampmann JP; Pedersen LE
    Pharmacol Toxicol; 1987 Feb; 60(2):151-5. PubMed ID: 3575249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phencyclidine blood protein binding: influence of protein, pH and species.
    Owens SM; Mayersohn M; Woodworth JR
    J Pharmacol Exp Ther; 1983 Sep; 226(3):656-60. PubMed ID: 6887006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anomalous relationship between free drug fraction and its total concentration in drug-protein systems II. Binding of different ligands to plasma proteins.
    Dawidowicz AL; Kobielski M; Pieniadz J
    Eur J Pharm Sci; 2008 Sep; 35(1-2):136-41. PubMed ID: 18644440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of lidocaine interactions with serum proteins using high-performance affinity chromatography.
    Soman S; Yoo MJ; Jang YJ; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):705-8. PubMed ID: 20138813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting quinidine protein binding in humans.
    Edwards DJ; Axelson JE; Slaughter RL; Elvin AT; Lalka D
    J Pharm Sci; 1984 Sep; 73(9):1264-7. PubMed ID: 6491948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
    Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
    HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):369-75. PubMed ID: 6631719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics of anti-arrhythmics. 2. Clinical applications].
    Lévy RH; Lévy S; Bricaud H
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1229-35. PubMed ID: 6778416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselective gallopamil protein binding.
    Gross AS; Eser C; Mikus G; Eichelbaum M
    Chirality; 1993; 5(6):414-8. PubMed ID: 8398599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of minaprine to human serum proteins and erythrocytes.
    Barré J; Houin G; Jeanniot JP; Coirre C; Tillement JP
    Int J Clin Pharmacol Res; 1986; 6(1):1-9. PubMed ID: 3957500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered plasma drug binding in cancer: role of alpha 1-acid glycoprotein and albumin.
    Jackson PR; Tucker GT; Woods HF
    Clin Pharmacol Ther; 1982 Sep; 32(3):295-302. PubMed ID: 7105620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
    Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
    Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolites of antiarrhythmic drugs: are they clinically important?
    Kates RE
    Ration Drug Ther; 1986 May; 20(5):1-5. PubMed ID: 3097754
    [No Abstract]   [Full Text] [Related]  

  • 37. Alpha 1-acid glycoprotein and albumin in human serum bupivacaine binding.
    Denson D; Coyle D; Thompson G; Myers J
    Clin Pharmacol Ther; 1984 Mar; 35(3):409-15. PubMed ID: 6697648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of different volatile inhaled anesthetics on the plasma protein binding of lidocaine].
    Kameue T
    Masui; 1991 Mar; 40(3):421-30. PubMed ID: 2072495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lidocaine protein binding in preeclampsia.
    Bottorff MB; Pieper JA; Boucher BA; Hoon TJ; Ramanathan J; Sibai BM
    Eur J Clin Pharmacol; 1987; 31(6):719-22. PubMed ID: 3556378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetic and pharmacodynamic effects of varying the free fraction of disopyramide.
    Shaw LM; Doherty JU; Waxman HL; Josephson ME
    Angiology; 1987 Feb; 38(2 Pt 2):192-7. PubMed ID: 3826754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.